Kbc Group Nv 10x Genomics, Inc. Transaction History
Kbc Group Nv
- $33.1 Billion
- Q3 2024
A detailed history of Kbc Group Nv transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,225 shares of TXG stock, worth $46,149. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,225
Previous 2,323
38.83%
Holding current value
$46,149
Previous $45,000
62.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TXG
# of Institutions
290Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$157 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$154 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$92.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$91.5 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$91.2 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.36B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...